The value of perioperative biomarker release for the assessment of myocardial injury or infarction in cardiac surgery
Schneider U, Mukharyamov M, Beyersdorf F, Dewald O, Liebold A, Gaudino M, Fremes S, Doenst T (2022)
Publication Type: Journal article, Review article
Publication year: 2022
Journal
Book Volume: 61
Pages Range: 735-741
Journal Issue: 4
Abstract
OBJECTIVES: Cardiac biomarkers are indicators of irreversible cell damage. Current myocardial infarction (MI) definitions require concomitant clinical characteristics. For perioperative MI, a correlation of biomarker elevations and mortality has been suggested. Definitions emerged relying on cardiac biomarker release only. This approach is questionable as several clinical and experimental scenarios exist where relevant biomarker release can occur apart from MI. METHODS: We reviewed the clinical and basic science literature and revealed important aspects regarding the use and interpretation of cardiac biomarker release with special focus on their interpretation in the perioperative setting. RESULTS: Ischaemic biomarkers may be released without cell death in multiple conditions, such as after endurance runs in athletes, temporary inotropic stimulation in animal models and flow variations in in vitro cell models. In addition, access through atrial tissue during cannulation or concomitant valve procedures adds sources of enzyme release that may not be related to ventricular ischaemia (i.e. MI). Such non-cell death-related mechanisms may explain the lack of poor correlations of enzyme release and long-term outcomes in recent trials. In addition, the 3 main biomarkers, troponin T, I and creatine kinase myocardial band, differ in their release kinetics, which may differentially trigger MI events in trial patients. CONCLUSIONS: The identification of irreversible myocardial injury in cardiac surgery based only on biomarker release is unreliable. Cell death- and non-cell death-related mechanisms create a mix in the perioperative setting that requires additional markers for proper identification of MI. In addition, the 3 most common ischaemic biomarkers display different release kinetics adding to the confusion. We review the topic.
Authors with CRIS profile
Involved external institutions
Friedrich-Schiller-Universität Jena
Germany (DE)
Universitätsklinikum Freiburg
Germany (DE)
Klinikum Oldenburg
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
Cornell University
United States (USA) (US)
University of Toronto
Canada (CA)
Germany (DE)
Universitätsklinikum Freiburg
Germany (DE)
Klinikum Oldenburg
Germany (DE)
Universitätsklinikum Ulm
Germany (DE)
Cornell University
United States (USA) (US)
University of Toronto
Canada (CA)
How to cite
APA:
Schneider, U., Mukharyamov, M., Beyersdorf, F., Dewald, O., Liebold, A., Gaudino, M.,... Doenst, T. (2022). The value of perioperative biomarker release for the assessment of myocardial injury or infarction in cardiac surgery. European Journal of Cardio-Thoracic Surgery, 61(4), 735-741. https://doi.org/10.1093/ejcts/ezab493
MLA:
Schneider, Ulrich, et al. "The value of perioperative biomarker release for the assessment of myocardial injury or infarction in cardiac surgery." European Journal of Cardio-Thoracic Surgery 61.4 (2022): 735-741.
BibTeX: Download